| Business Summary | | Cell
Tech
International
owns,
under
license,
the
exclusive
rights
in
the
United
States
and
Canada
to
manufacture
and
market
a
device
called
the
BreastAlert
Differential
Temperature
Sensor
(the
BreastAlert
device).
The
BreastAlert
device
is
a
non-invasive,
easy-to-use,
low-cost,
adjunctive
test
to
be
used
by
primary
care
physicians,
gynecologists
and
other
medical
specialists
as
part
of
a
breast
disease
monitoring
program
along
with
breast
self-examination
(BSE),
palpation
and
mammography
and
other
established
clinical
procedures
including
ultrasound
and/or
biopsy.
If
the
BreastAlert
device
indicates
that
one
breast
is
emitting
more
heat
than
the
other,
the
physician
is
alerted
to
the
possibility
of
a
physiological
condition,
including
proliferating
heat-emitting
cancer
cells
or
certain
types
of
heat-emitting
breast
disease
that
may
require
medical
treatment. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Cell
Tech
is
a
vertically
integrated
manufacturer
and
retailer
of
a
broad
line
of
nutritional
supplements
in
the
US.
Cell
Tech
has
been
harvesting
and
distributing
Aphanizomenon
flosaquae
algae
as
a
nutritional
supplement
under
the
trade
name
Super
Blue
Green(R)
Algae.
For
the
nine
months
ended
9/98,
revenues
fell
34%
to
$301
thousand.
Net
loss
totalled
$8.7
million,
up
from
$2.4
million.
Results
reflect
lower
interest
income
and
the
inclusion
of
a
$2.9
million
special
charge. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY1997 Pay | |
| Marta Kollman Pres
and CEO | -- | Kenneth Hollander, 32 CFO | $123K | Dollar
amounts are as of 31-Dec-1997 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|